(Q43669944)

25 November 2017

title

Pneumococcal otitis media and pneumococcal vaccines, a historical perspective (English)

1 reference

25 November 2017

1 reference

Austrian R

1

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

25 November 2017

1 reference

25 November 2017

volume

19 Suppl 1

1 reference

25 November 2017

page(s)

S71-7

1 reference

Temporal Bone Preservation in a 2600-Year-Old Egyptian Mummy

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

A Bacteriological Investigation of the Suppurative Discharge Occurring as a Complication in Scarlet Fever

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

A CONTRIBUTION TO THE PHYSIOLOGICAL DIFFERENTIATION OF PNEUMOCOCCUS AND STREPTOCOCCUS, AND TO METHODS OF STAINING CAPSULES.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

AN IMMUNOLOGICAL STUDY OF PNEUMOCOCCUS MUCOSUS.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

ANTIBODY FORMATION IN VOLUNTEERS FOLLOWING INJECTION OF PNEUMOCOCCI OR THEIR TYPE-SPECIFIC POLYSACCHARIDES.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

THE ELABORATION OF SPECIFIC SOLUBLE SUBSTANCE BY PNEUMOCOCCUS DURING GROWTH.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

CUTANEOUS REACTIONS IN PNEUMONIA. THE DEVELOPMENT OF ANTIBODIES FOLLOWING THE INTRADERMAL INJECTION OF TYPE-SPECIFIC POLYSACCHARIDE.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

SPECIFIC CUTANEOUS REACTIONS AND CIRCULATING ANTIBODIES IN THE COURSE OF LOBAR PNEUMONIA : I. CASES RECEIVING NO SERUM THERAPY.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

Pneumococcal vaccine efficacy in selected populations in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

The Clinical Effectiveness of Pneumococcal Vaccine in the Elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

Experimental Otitis Media Due to Streptococcus pneumoniae: Immunopathogenic Response in the Chinchilla

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

Modification of Otitis Media Following Vaccination with the Capsular Polysaccharide of Streptococcus pneumoniae in Chinchillas

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

The pathogenesis of pneumococcal otitis media in chinchillas and the efficacy of vaccination in prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

Prevention of pneumococcal otitis media in chinchillas with human bacterial polysaccharide immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

Clinical Studies of Pneumococcal Vaccines in Infants. II. Efficacy and Effect on Nasopharyngeal Carriage

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

Use of pneumococcal vaccine for prevention of recurrent acute otitis media in infants in Boston. The Greater Boston Collaborative Otitis Media Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

Efficacy of Pneumococcal Polysaccharide Vaccine in Preventing Acute Otitis Media in Infants in Huntsville, Alabama

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

A study of the pneumococcal vaccine in prevention of clinically acute atttacks of recurrent otitis media.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

Antibody response to pneumococcal vaccination in children younger than five years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

Pneumococcal vaccine in normal children. Primary and secondary vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

Thymus-independent antigens: complexity of B-lymphocyte activation revealed

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

Thymus-independent and thymus-dependent responses to polysaccharide antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

IMMUNOLOGICAL REACTIONS OF THE ISOLATED CARBOHYDRATE AND PROTEIN OF PNEUMOCOCCUS

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : I. THE SYNTHESIS OFp-AMINOPHENOL beta-GLUCOSIDE, p-AMINOPHENOL beta-GALACTOSIDE, AND THEIR COUPLING WITH SERUM GLOBULIN.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : II. IMMUNOLOGICAL SPECIFICITY OF SYNTHETIC SUGAR-PROTEIN ANTIGENS.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : IV. THE SYNTHESIS OF THEp-AMINOBENZYL ETHER OF THE SOLUBLE SPECIFIC SUBSTANCE OF TYPE III PNEUMOCOCCUS AND ITS COUPLING WITH PROTEIN.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : V. THE IMMUNOLOGICAL SPECIFITY OF AN ANTIGEN PREPARED BY COMBINING THE CAPSULAR POLYSACCHARIDE OF TYPE III PNEUMOCOCCUS WITH FOREIGN PROTEIN.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : XII. THE IMMUNOLOGICAL PROPERTIES OF AN ARTIFICIAL ANTIGEN CONTAINING CELLOBIURONIC ACID.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

STUDIES ON ANTIBACTERIAL IMMUNITY INDUCED BY ARTIFICIAL ANTIGENS : I. IMMUNITY TO EXPERIMENTAL PNEUMOCOCCAL INFECTION WITH AN ANTIGEN CONTAINING CELLOBIURONIC ACID

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

Pneumococcal conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900282-6

7 January 2021

10.1016/S0264-410X(00)00282-6

Identifiers

DOI

1 reference

25 November 2017

1 reference